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 We described an exclusively in vitro procedure for cloning and 
recloning bovine embryos.  Embryos obtained by IVM/IVF/IVC developed to the 
morula stage were used as blastomere donors in cunjunction with IVM recipient 
oocytes.  Reconstructed embryos were developed in vitro in co-culture using bovine 
oviductal epithelial cells.  The resulting morulae were used as donors for recloning 
under the same experimental conditions.  No significant difference was observed 
between cloning and recloning in terms of development (rates of blastocysts: 12.9 
versus 14.9%), in the number of nuclei per blastocyst (63.8 versus 49.1), or in 
pregnancy rates (35.7 versus 33.3%).  The high variability observed between replicates 
and the correlation between results in first and second cycle nuclear transfer may 
suggest an inherant potential of individual donor embryos to support development by 
cloning. 
 




 Development of reproducible cloning methods in mammals is of 
considerable scientific and economic interest.  Due to the relatively small number of 
offspring obtained after a single cycle of nuclear transfer, some authors have suggested 
the use of viable reconstructed embryos as donors for second or additional cycles of 
nuclear transfer.  Recloning of mammalian embryos has been reported by Willadsen et 
al (9), Westhusin et al (8) and Stice and Keefer (7).  The latter authors have described 
the attainment of live calves after 3 generations of nuclear transfer. 
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 Reports on the potential of preimplantation development of nuclear 
transplanted bovine embryos have varied considerably within and between laboratories.  
Two main factors might account for this variability: donor and recipient cell cycle 
compatibility (1) and/or partial ability of the recipient cytoplasm to undifferentiate the 
donor nucleus.  In addition, Stice and Keefer (7) have postulated that some donor 
embryos may have an intrinsic potential to support proper development after multiple 
nuclear transfers. 
 
 We described a nuclear transfer procedure in conjunction with in vitro 
embryo culture.  Donor embryos were produced by IVM, IVF and in vitro culture.  
Development of reconstituted embryos was performed in vitro in co-culture with bovine 
oviductal epithelial cells.  Some of these reconstituted embryos were used as donors for 
recloning.  Afterwards, a limited number of embryos was evaluated in vitro by counting 
nuclei.  Relatively large numbers of first and second cycle blastocysts obtained by 
nuclear transfer were implanted into synchronous recipient heifers in order to evaluate 
their ability to induce ongoing pregnancies. 
 
MATERIALS AND METHODS 
 
 Two experiments were conducted: in Experiment 1, first cycle nuclear 
transfer embryos were produced, while in Experiment 2 the first cycle reconstructed 




 In vitro maturation of oocytes and in vitro fertilization of donor 
embryos have been previously described (2).  Micromanipulations were carried out on 
an inverted Nikon Diaphot microscope(x100 magnification) equipped with Leitz 
mechanical micromanipulators.  All the micromanipulation procedures were performed 
at 25 to 30°C, in 250-µl doplets under oil (light mineral oil, Sigma Chemical, St. Louis 
MO; M-3516). 
 
 Oocyte enucleation.  After 24 h of IVM, expanded ovocyte-cumulus 
complexes were placed in calcium- and magnesium-free PBS medium supplemented 
with hyaluronidase (300 IU/ml; Sigma: H-3506) and vigorously shaken for 5 min 
(vortexed) to remove the cumulus cells.  Denuded oocytes with a homogeneous 
cytoplasm and a first polar body were selected as recipient cytoplasms. 
 
 These oocytes were placed in PBS added with 10% fetal calf serum 
(FCS: Sebak: ref.: 30.01.21) containing cytochalasin B (7.5 µg/ml; Sigma: C-6762) 10 
min before starting the micromanipulations.  For enucleation of oocytes, a small amount 
(≈1/3) of cytoplasm adjacent to the first polar body and the first polar body itself was 
removed by aspiration.  Immediately after enucleation, the micromanipulated oocytes 
were incubated at room temperature in PBS containing 10% FCS and Hœchst 33342 (5 
µg/ml; bisbenzimide trihydrochloride, Sigma: B-2261) for 10 min.  After staining, the 
micromanipulated oocytes were rinced in fresh PBS added with 10% FCS and then 
examined individually at x100 magnification with a Nikon TMD Diaphot inverted 
microscope equipped with an epifluorescence detector.  A 100-watt mercury lamp 
(Osram, Germany) and an ultraviolet filter block (365 nm excitation and 400 nm 
emission, UV-1A, Nikon) were used to irradiate the oocytes.  Exposition of oocytes to 
UV light lasted no more than 5 sec.  Only oocytes with no observable chromatin were 
considered as correctly enucleated, and were used as recipient cytoplasm for an isolated 
blastomere.  The enucleated oocytes were then returned to maturation medium at 39°C 
until 44 to 46 h post-onset of IVM. 
 Donor embryos.  In Experiments 1 and 2, donor embryos were used 
on Day 5 after IVF (Day 0 = IVF); in Experiment 2, morulae were used on Day 6 after 
first cycle nuclear transfer for recloning (Day 0 = Day of enucleation).  After selection, 
they were incubated in calcium- and magnesium-free PBS + 10% FCS containing 
cytochalasin B (7.5 µg/ml) for 10 min.  Each donor was placed individually in a 25-µl 
droplet under oil.  The embryonic cell mass was mechanically removed from its zona 
pellucida with a glass needle mounted on a micromanipulator.  The blastomeres were 
disaggregated by gentle pipetting throughout a calibrated holding pipette (inner 
diameter: ≈30 µm). 
 
 Injection and fusion.  Immediately after the disaggregation of the 
donor morula, an appropriate number of recipient cytoplasms was added to the droplet 
containing the isolated blastomeres.  Single blastomeres isolated from approximately 
32-cell embryos were inserted into the perivitelline space of enucleated oocytes.  
Injection was performed via the hole remaining in the zona pellucida from the day 
before.  Recipient oocyte-blastomere pairs were transferred to the electrofusion 
medium: 0.275 M mannitol (Sigma, ref.: M-1902) added with 0.1 mM MgSO4.7H2O 
(Sigma, ref.: M-7774) and 0.05 mM CaCl2 (Sigma, ref.: C-7902).  The pairs were gently 
placed in a home-made fusion chamber with 2 platinium parallel electrodes 240 µm 
apart.  A direct current pulse of 2.7 kVolts/cm was applied for 50 microsec.  An electric 
fusion processor was used as pulse generator (Jouan, CHT 1287; Saint-Herblain, 





 The bovine oviducts were recovered at a local slaughterhouse from 
normally cycling heifers presenting a corpus luteum.  They were carried to the 
laboratory in saline at 0°C within 1 h.  After dissection, the fallopian tubes were washed 
by immersion in ethanol for a few seconds and then rinsed 3 times in saline.  The 
scratching of the oviductal mucosae was performed using a glass microscope slide.  
After washing the cells 5 times in PBS + 10% FCS, they were cultured for 24 h in TCM 
199 supplemented with 20% FCS and antibiotics/antimicotic preparation (penicillin: 
100 IU/ml, streptomycin: 100 µg/ml and amphotericin B: 1 µg/ml - Life Technologies, 
Inc., Grand Island NY; USA; ref.: 600-5245AE).  Before use for embryo culture, they 
were washed twice in PBS + 10% FCS to remove the dead cells.  After washing, the 
tissue pellet was resuspended in Menezo B2 medium (tissue/medium ratio of 1/50) 
supplemented with 20% heat-treated proestrus cow serum (Day 20), pyruvate (30 
µg/ml), antibiotics (penicillin: 100 IU/ml, streptomycin: 100 µg/ml).  The zygotes or 
reconstructed embryos were cultured in 50-µl droplets of tissue suspension under oil. 
 
 Embryos were classified on Day 3 as cleaved (II-cell, IV-cell and 
VIII-cell stages) and as VIII-cell stages, on Day 5 or 6 as morula or on Day 7 as 
blastocyst. 
 
 Blastocyst quality obtained from first and second cycle nuclear 
transfer was assessed in vitro by counting the nuclei or in vivo by their ability to induce 
gestation in synchronized heifers. 
 
 Blastocyst fixing and staining.  On Day 7, a portion of the blastocysts 
was fixed in ethanol/2.3% NaCitrate (1/3: v/v) to determine the cell number based on 
the nuclear counts after staining with Hœchst 33342 (10 µg/ml). 
 
 Embryo transfer.  Red Holstein heifers were synchronized by 
intramuscular injection of 750 µg (3 ml) of cloprostenol (Estrumate, Pitman-Moore) 
about 60 h before the onset of desired estrus.  Blastocysts obtained in co-culture after 
nuclear transfer were transferred non surgically to recipient heifers 7 d after estrus.  
Two embryos of comparable quality from the same blastomere donor were transferred 
together into the recipient's uterine horn ipsilateral to the corpus luteum.  Pregnancies 
were diagnosed on Day 35 by pregnancy-associated glycoprotein (PAG) determination 
(11).  All pregnant recipients were examined after 90 d of gestation by palpation per 




 Data were analyzed by Chi-square (Tables 1 and 2) and of Student's t-
test (Tables 3 and 4).  Correlations between development after first and second cycle 




Experiment 1: First Cycle Nuclear Transfer 
 
 On average, 19.1 (248/13) reconstructed embryos were obtained per 
donor.  The development potential of first cycle nuclear transfer embryos was compared 
to that of embryos produced by IVF (Table 1).  Although similar cleavage rates were 
obtained in both groups, first cycle reconstructed embryos had significantly lower 
development rates to 8-cell and later development stages (P<0.01).  Moreover, 
substantially higher standard errors and wider ranges were obtained in the reconstructed 




Table 1. Percentage of embryos developing after IVF and first cycle nuclear transfer 
                                                                                                                                                         
  Mean % ±SEM Range Number Replicates 
                                                                                                                                                         
 
IVF: 
 Cleaved (Day 3) 76.0 ± 4 60 to 86 (511/672) 6 
 8-cell stage (Day 3) 49.1 ± 4 34 to 59 (330/672) 6 
 Morula (Day 5) 21.4 ± 4 20 to 43 (144/672) 6 
 
First cycle nuclear transfer: 
 Cleaved (Day 3) 68.7 ± 15 35 to 83 (170/248) 13 
 8-cell stage (Day 3) 21.8 ± 16 0 to 41 (54/248) 13 
 Blastocysts (Day 7) 12.9 ± 10 0 to 27 (32/248) 13 




Experiment 2: Second Cycle Nuclear Transfer 
 
 The mean number of reconstructed embryos obtained per donor was 
similar in first (228/11) and second (303/15) cycle nuclear transfer (20.7 versus 20.2; 
P>0.05).  As shown in Experiment 1, cleavage rate in IVF was similar to that in first 
and second cycle nuclear transfer; whereas the development to 8-cell and later stages 
was significantly lower in both reconstructed groups (Table 2). 
 
 No significant difference was observed at any stage between first and 
second cycle nuclear transfer embryos.  Standard errors and ranges observed in the 
reconstructed embryos were also higher than in the IVF group.  No difference in these 
parameters was observed between first and second cycle nuclear transfer groups, 
indicating that increased variability observed after cloning was not influenced by a 
recloning procedure. 
 
 To evaluate a possible donor effect, first cycle nuclear transfer 
embryos obtained in Experiment 2 were classified according to the development rate 
(Table 3).  In Table 3, when the first cycle nuclear transfer embryos obtained in 
Experiment 2 were classified according to the development rate, there was evidence of a 
possible donor effect, but the correlation between the first and second cycle was weak. 
 
 
Table 2. Percentage of embryos developing after IVF, first and second cycle nuclear 
transfer 
                                                                                                                                                         
  Mean % ±SEM Range Number Replicates 
                                                                                                                                                         
 
IVF: 
 Cleaved (Day 3) 76.5 ± 10 60 - 86 (485/634) 5 
 8-cell (Day 3) 48.4 ± 11 34 - 59 (307/634) 5 
 Morula (Day 5) 23.8 ± 6 20 - 35 (151/634) 5 
 
First cycle nuclear transfer: 
 Cleaved (Day 3) 86.8 ± 17 41 to 92 (198/228) 11 
 8-cell (Day 3) 22.8 ± 10 8 to 36 (52/228) 11 
 Morula (Day 6) 14.5 ± 12 0 to 30 (33/228) 11 
 
Second cycle nuclear transfer: 
 Cleaved (Day 3) 78.2 ± 7 66 to 89 (237/303) 8 
 8-cell (Day 3) 28.7 ± 9 18 to 43 (87/303) 8 
 Blastocysts (Day 7) 14.9 ± 12 0 to 41 (45/303) 8 
                                                                                                                                                         
 
 
 Two tests were performed to evaluate the quality of first and second 
cycle nuclear transfer blastocysts obtained in the Experiments 1 and 2 described above.  
Some embryos were fixed and stained in order to determine their nuclear number (Table 
4), while others were non-surgically transferred to recipient heifers (Table 5). 
 A reduced number of nuclei was observed in blastocysts from nuclear 
transfer embryos when compared to IVF embryos (P<0.0005).  Moreover, the number 
of nuclei observed in recloned blastocysts was also reduced when compared with those 
of first cycle nuclear transfer, but the results were not significantly different (P>0.05).  
The absence of a quality difference between cloned and recloned blastocysts was 
confirmed by the similar rates of pregnancies obtained in the 2 groups (Table 5). 
 
 
Table 3. Developmental potential of cloned embryos over 2 cycles 
 
                                                                                                                                                        
Donors Cycle 1 Cycle 2 
 Morulae (Day 6) Blastocysts (Day 7) 
 n % n % 
                                                                                                                                                         
 
1 9/30 30.0 9/56 16.1 
2 6/22 27.3 15/37 40.1 
3 5/26 19.2 2/33 6.1 
4 4/22 18.2 1/10 10.0 
5 3/21 14.3 6/37 16.2 
6 2/17 11.8 6/40 15.0 
7 3/30 10.0 6/43 14.0 
8 1/11 9.1 0/47 0.0 
9 0/12 0.0 / / 
10 0/15 0.0 / / 
11 0/22 0.0 / / 
 
Totals 33/228 14.5 45/303 14.9 
                                                                                                                                                         
Parent donor embryos were classified by function of their developmental rate after the 
first cycle nuclear transfer . 
Correlation between Cycle 1 and 2 nuclear transfers: r2 = 0.58; P=0.13. 
 
 
 A total of 11 calves were obtained in the first and the second 
experiments.  All of them were morphologically normal and presented normal 
karyotypes.  In the second cycle nuclear transfer group, we obtained the clones of male 
twins and of female triplets. 
  
Table 4. Number of nuclei in IVF, Cycle 1 and 2 nuclear transfer Day 7 blastocysts 
                                                                                                                                                         
 Mean n of nuclei Range No. of fixed 
 (± SEM)  blastocysts 
                                                                                                                                                        
 
IVF 105.2 ± 3.21 69-148 48 
Experiment 1 (Cycle 1 nuclear transfer) 63.8 ± 4.9 35-135 25 
Experiment 2 (Cycle 2 nuclear transfer) 49.1 ± 5.0 30-83 11 
                                                                                                                                                         
 
 
Table 5. Percentage of pregnancies following transfer of 2 blastocysts from Cycle 1 
and 2 nuclear transfers a. 
                                                                                                                                                         
  Day 35 Day 90 Term Newbornb 
                                                                                                                                                         
 
Experiment 1 (Cycle 1 nuclear transfer) 
 % 50.0 50.0 35.7 21.4 
 n 7/14 7/14 5/14 6/28 
 
Experiment 2 (Cycle 2 nuclear transfer) 
 % 50.0 33.3 33.3 20.8 
 n 6/12 4/12 4/12 5/24 
                                                                                                                                                         
a: All recipients heifers received two embryos from the same clone. 





 Our results demonstrate that viable multiple generation nuclear 
transfer embryos can be obtained through an exclusively in vitro procedure for cloning 
and recloning in the bovine species.  Previous reports on multiple generation nuclear 
transfer have shown that 2 or more generations of nuclear transfer embryos can be 
produced when using in vivo donor embryos and by culturing the nuclear transfer 
embryos in the oviducts of intermediate hosts, either sheep or rabbit (7,8).  
Developmental rates to the blastocyst stage similar to those reported using in vivo 
procedures have been obtained in vitro (3), suggesting that temporary passage in the 
reproductive tract of nuclear transfer embryos is not necessary.  In vitro derived donor 
embryos have previously been shown to support the development of single generation 
nuclear transfer embryos with a potential to produce live offspring (3,5,10).  Although 
some authors have reported reduced development from in vitro donor embryos (10), 
others have shown similar development rates of nuclear transfer embryos derived from 
in vitro and in vivo donor embryos (2,3). 
  
 Significantly lower developmental rates and lower nuclei counts in 
blastocysts were observed in both first and second cycle nuclear transfer derived 
embryos when compared with these of IVF embryos.  This loss in potential may, 
however, not always be present, since others have shown similar rates of development 
between first cycle nuclear transfer and IVF embryos (3).  Similar to the findings of 
Westhusin et al (6) and Stice et al (5), our experiments show no change in development 
potential between first and second generation clones.  All 3 viability parameters studied, 
(i.e., blastocyst development rates, nuclei number in Day 7 blastocysts, and pregnancy 
rates) showed a remarkable similarity between both nuclear transfer groups, indicating 
that viability is not affected by a second round of nuclear transfer.  These findings are in 
contrast with those reported by Stice and Keefer (5) and Westhusin et al (7), who 
showed decreased development in second cycle nuclear transfer embryos.  It is 
somewhat surprising that an embryo, or its genome, can remain viable after being 
cultured entirely in vitro for up to 18 d (Cycle 2).  In addition to the prolonged in vitro 
culture period, Cycle 2 embryos undergo 2 cycles of micromanipulation comprised of 
exposure to conditions such as low temperature, UV irradiation, microsurgery, 
cytoskeletal inhibitors and electric pulses.  The cytoplasm and plasma membrane, 
however, are renewed at each cycle of nuclear transfer, bringing, apart from these non 
genetic components, fresh (viable) post-transcriptional machinery wich enables several 
cleavage divisions at limited or no expense to the transplanted nucleus.  On the contrary, 
repeated exposure of the chromatin to reprogramming factors in the cytoplasm of 
oocytes may even enhance developmental potential, as, is indicated in the amphibian 
(6).  In support of this notion, Stice and Keefer (5) reported a rebound in development 
rates after third and fourth cycles of bovine nuclear transfer (5).  The latter, however, 
appear to produce lower pregnancy rates and fewer live offspring. 
 
 Like Westhusin et al (6) and Stice and Keefer (5), we observed a large 
variability in the percentages of blastocysts between the first and second cycle of 
nuclear transfer.  In our study, the between replicate variability (expressed as the 
coefficient of variation: CV) for in vitro blastocyst development was low in the IVF 
program (19 and 25%).  In contrast, after cloning it increased greatly but was not 
amplified in the second cycle when compared with that of the first cycle (80.5 versus 
77.5%).  As noted by others (7), the origin of such inter-replicate variability remains 
unclear.  A nuclear donor effect is most likely a cause of inter-replicate variation since 
only a small number of donor embryos is used in any micromanipulation session.  As 
suggested by Stice and Keefer (5), nuclei from different embryos may have variable 
intrinsic potential to support development after nuclear transfer.  Such intrinsic potential 
of donor embryos should be transmitted through generations of multiple nuclear 
transfers, leading to a clonal family effect.  In our study, a positive correlation (r2=0.58) 
but not a significant (P=0.13) one was observed between the development of first and 
second cycles of nuclear transfer embryos.  However, since clonal families that produce 
no embryos in first nuclear transfer cycle provide no information for the second 
generation, it is possible that this correlation value is biased.  If we assume that the 
donor embryos which are not able to support development at the first cycle nuclear 
transfer are also unable to do so in the second cycle, then the resulting correlation value 
is higher (r2=0.74) and significant (P<0.01).  Moreover, clustering of our clonal families 
into high (21 to 30%; Donors 1 and 2), average (11 to 20%; Donors 3 to 7) and low (0 
to 10%; Donors 8 to 11) groups at the first cycle nuclear transfer indicates that, with a 
few exceptions, the development of most second cycle nuclear transfer embryos 
remained in the same group or fell to the group just below (Table 3).  Further 
investigations are needed to determine whether or not a clonal family effect is present in 
nuclear transfer, and if these donor embryos can be identified prior to the cloning 
procedure.  Screening of good donor embryos would allow for the production of larger 
numbers of genetically identical embryos and would lead to a substantial improvement 
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